Picture of Immuron logo

IMC — Immuron News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Immuron Ltd Says Positive Results Support Travelan Progress To Phase 3 Clinical Trials In US

March 7 (Reuters) - Immuron Ltd  IMC.AX :
    * POSITIVE RESULTS SUPPORT TRAVELAN PROGRESS TO PHASE 3
CLINICAL
TRIALS IN US

Further company coverage:  IMC.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Immuron

See all news